Illumina reagent chemistry kits
Active Awarded Last action
- Contract number
- 75F40126F19062
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $60,985
Award facts
- Contract value 100% obligated
- $60,984.74 Current and potential, with all options
- Completion date 27% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Laurel, MD, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a delivery order to Illumina, Inc. for Illumina reagent chemistry kits with a ceiling value of approximately $61K under a firm fixed-price contract structure. The delivery order, issued on March 26, 2026, has an ultimate completion date of April 30, 2028, with performance taking place in Laurel, Maryland. No small business set-aside designation was used for this procurement. Illumina, a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, will provide essential laboratory reagents and consumables supporting the FDA's diagnostic and research capabilities.
This delivery order likely falls under a broader indefinite delivery vehicle or blanket purchase agreement, consistent with Illumina's extensive federal contracting history across multiple civilian agencies including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs. Illumina's reagent chemistry kits are critical components of the company's DNA and RNA sequencing systems, enabling genomic research and diagnostic applications across federal laboratories. The modest award value reflects a routine consumables procurement, typical of task orders issued against established relationships with the vendor. As a specialized sole-source provider of proprietary sequencing technologies and associated materials, Illumina has become a foundational technology provider for contemporary genomic research operations throughout the federal government.
Quick answers
Who was awarded contract 75F40126F19062?
75F40126F19062 was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on March 26, 2026.
How much is contract 75F40126F19062 worth?
The government has obligated $60,985 on 75F40126F19062.
Is contract 75F40126F19062 an order under another contract?
Yes. 75F40126F19062 is a delivery order under 75F40123D00001, an indefinite delivery contract.
Was contract 75F40126F19062 competed?
The extent of competition for 75F40126F19062 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award